Market Value2,254,350,000
Total Holdings54
File Date2021-08-16
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
NKTX / Nkarta, Inc.
HRMY / Harmony Biosciences Holdings, Inc.
US2103731061 / Constellation Pharmaceuticals Inc
XENT / Intersect ENT Inc
EAR / Eargo, Inc.
PRAX / Praxis Precision Medicines, Inc.
INSP / Inspire Medical Systems, Inc.
VERV / Verve Therapeutics, Inc.
GRAY / Graybug Vision Inc
SPNE / SeaSpine Holdings Corp
CMPI / Checkmate Pharmaceuticals Inc
IOVA / Iovance Biotherapeutics, Inc.
VECT / VectivBio Holding AG
FLXN / Horizon Funds - Horizon Flexible Income ETF
SPRB / Spruce Biosciences, Inc.
GRTS / Gritstone bio, Inc.
AFIB / Acutus Medical, Inc.
INZY / Inozyme Pharma, Inc.
ALNY / Alnylam Pharmaceuticals, Inc.
LEGN / Legend Biotech Corporation - Depositary Receipt (Common Stock)
LVTX / LAVA Therapeutics N.V.
ZGNX / Zogenix Inc
FSTX / F-star Therapeutics Inc
BAMR / Brookfield Reinsurance Ltd (Exchangeable Shares, Sub Voting) - Class A
BHVN / Biohaven Ltd.
AKUS / Akouos Inc
VRNA / Verona Pharma plc - Depositary Receipt (Common Stock)
AERI / Aerie Pharmaceuticals Inc
BAM / Brookfield Asset Management Ltd.
US35655L1070 / Freeline Therapeutics Holdings PLC
ALGS / Aligos Therapeutics, Inc.
BOLT / Bolt Biotherapeutics, Inc.
LUNG / Pulmonx Corporation
TMCI / Treace Medical Concepts, Inc.
INGN / Inogen, Inc.
NARI / Inari Medical, Inc.
PTGX / Protagonist Therapeutics, Inc.
MIST / Milestone Pharmaceuticals Inc.
MIRM / Mirum Pharmaceuticals, Inc.
ABCL / AbCellera Biologics Inc.
PHVS / Pharvaris N.V.
CYT / Cyteir Therapeutics, Inc.
RPHM / Reneo Pharmaceuticals, Inc.
GRTX / Galera Therapeutics, Inc.
KNTE / Kinnate Biopharma Inc.
VTI / Vanguard Index Funds - Vanguard Total Stock Market ETF
FOLD / Amicus Therapeutics, Inc.
SILK / Silk Road Medical, Inc
CABO / Cable One, Inc.
PCVX / Vaxcyte, Inc.
MORF / Morphic Holding, Inc.
SPRO / Spero Therapeutics, Inc.
AAPL / Apple Inc.
EWTX / Edgewise Therapeutics, Inc.
CRNX / Crinetics Pharmaceuticals, Inc.
GLTO / Galecto, Inc.
INSM / Insmed Incorporated
BPMC / Blueprint Medicines Corporation
BABA / Alibaba Group Holding Limited - Depositary Receipt (Common Stock)